.Pharmacolibrary.Drugs.R_RespiratorySystem.R06A_AntihistaminesForSystemicUse.R06AX32_Sequifenadine.Sequifenadine .Pharmacolibrary.Drugs.R_RespiratorySystem.R06A_AntihistaminesForSystemicUse.R06AX32_Sequifenadine.Sequifenadine| name: | Sequifenadine |
| ATC code: | R06AX32 | route: | oral |
| n-compartments | 1 |
Sequifenadine is a non-sedating antihistamine drug, primarily developed and used in Russia for the treatment of allergic conditions like allergic rhinitis and urticaria. It acts as a selective H1 receptor antagonist. The drug is not widely approved or in use outside of some Eastern European countries.
Estimated pharmacokinetic parameters for healthy adult subjects based on comparable oral second-generation antihistamines, as no direct human pharmacokinetic studies are published or referenced in scientific literature.